Pliant Therapeutics, Inc. (PLRX)
1.16
0.00 (0.00%)
USD |
NASDAQ |
Jun 11, 15:02
Pliant Therapeutics Total Assets (Quarterly) : 202.60M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 202.60M |
| December 31, 2025 | 230.57M |
| September 30, 2025 | 276.60M |
| June 30, 2025 | 299.82M |
| March 31, 2025 | 344.77M |
| December 31, 2024 | 396.95M |
| September 30, 2024 | 445.66M |
| June 30, 2024 | 483.73M |
| March 31, 2024 | 521.60M |
| December 31, 2023 | 512.15M |
| September 30, 2023 | 540.46M |
| June 30, 2023 | 574.89M |
| March 31, 2023 | 597.88M |
| Date | Value |
|---|---|
| December 31, 2022 | 350.61M |
| September 30, 2022 | 377.18M |
| June 30, 2022 | 184.62M |
| March 31, 2022 | 197.02M |
| December 31, 2021 | 221.22M |
| September 30, 2021 | 234.12M |
| June 30, 2021 | 255.72M |
| March 31, 2021 | 275.25M |
| December 31, 2020 | 295.53M |
| September 30, 2020 | 312.32M |
| June 30, 2020 | 328.80M |
| March 31, 2020 | 184.06M |
| December 31, 2019 | 119.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 108.37M |
| CorMedix, Inc. | 815.64M |
| Eloxx Pharmaceuticals, Inc. | 8.503M |
| Cannabis Global, Inc. | 0.885M |
| BioStem Technologies, Inc. | 55.08M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.43M |
| Shareholders Equity (Quarterly) | 165.17M |
| Debt to Equity Ratio | 0.1743 |
| Current Ratio | 16.89 |
| Net Debt Paydown Yield | 8.05% |